Vertex Pharmaceuticals Incorporated (ETR: VX1)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	98,216	94,857	69,361	49,095	50,241	50,172
Market Cap Growth	26.92%	36.76%	41.28%	-2.28%	0.14%	35.65%
Enterprise Value	89,141	83,201	60,990	43,745	45,660	47,189
Last Close Price	377.20	371.20	270.10	197.14	191.32	196.82
PE Ratio	-	28.97	22.31	23.84	22.66	47.84
PS Ratio	11.30	10.62	8.30	7.37	9.90	13.53
PB Ratio	7.68	5.96	5.33	5.53	7.07	9.25
P/TBV Ratio	8.75	6.70	6.07	6.42	8.44	12.02
P/FCF Ratio	-	31.42	18.88	23.18	20.53	37.69
P/OCF Ratio	-	29.64	17.95	21.12	18.89	35.88
EV/Sales Ratio	8.74	9.32	7.30	6.57	9.00	12.72
EV/EBITDA Ratio	20.63	20.54	14.40	12.38	17.66	40.46
EV/EBIT Ratio	21.91	21.35	14.89	12.78	18.29	44.06
EV/FCF Ratio	-89.91	27.56	16.61	20.66	18.66	35.45
Debt / Equity Ratio	0.11	0.05	0.06	0.10	0.11	0.11
Debt / EBITDA Ratio	0.39	0.18	0.20	0.24	0.30	0.51
Debt / FCF Ratio	-	0.24	0.23	0.40	0.31	0.45
Asset Turnover	0.48	0.48	0.57	0.60	0.62	0.57
Inventory Turnover	5.58	7.38	8.87	8.97	10.62	15.78
Quick Ratio	2.08	3.60	4.46	4.04	4.02	3.33
Current Ratio	2.47	3.99	4.83	4.46	4.33	3.61
Return on Equity (ROE)	-2.99%	22.99%	27.67%	24.93%	36.71%	22.37%
Return on Assets (ROA)	12.05%	13.17%	17.33%	19.32%	19.02%	10.32%
Return on Capital (ROIC)	15.29%	16.22%	21.15%	23.51%	23.30%	12.75%
Earnings Yield	-0.40%	3.45%	4.48%	4.19%	4.41%	2.09%
FCF Yield	-0.92%	3.18%	5.30%	4.31%	4.87%	2.65%
Buyback Yield / Dilution	0.91%	-0.54%	0.31%	1.33%	-1.04%	-0.58%
Total Shareholder Return	0.91%	-0.54%	0.31%	1.33%	-1.04%	-0.58%

Source: S&P Capital IQ. Standard template. Financial Sources.